Cost Effectiveness of Ventricular Tachycardia Ablation Versus Escalation of Antiarrhythmic Drug Therapy The VANISH Trial

Overview of attention for article published in JACC: Clinical Electrophysiology, March 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

news: 1 news outlet
twitter: 27 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 28 Dimensions

Readers on

mendeley: 47 Mendeley

Summary News X Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

JACC Journals - Journals of the American College of Cardiology, 29 May 2018

Editors' Insights: Should we be ablating VT before escalation of anti-arrhythmic drug therapy? Ablation is found cost-effective…